Huawei rolled out its D3 smartwatch on September 23, 2026, in the UK, marking the first consumer wearable to embed an inflatable blood‑pressure cuff—an innovation that turns a wrist‑watch into a portable cuffed monitor.
The D3 uses an oscillometric method, combining a mechanical cuff with a pressure sensor to deliver both systolic and diastolic readings. Huawei claims the watch supports ambulatory blood‑pressure monitoring (ABPM), capturing data over 24 hours at regular intervals for a professional report that can be shared with a GP. The company secured CE‑MDR medical certification, a first for a consumer smartwatch, signalling regulatory compliance for medical‑grade measurement.
Technically, the watch is only 11.3 mm thick and weighs 40 grams, sporting a 1.92‑inch AMOLED display that peaks at 3,000 nits. It runs on both iOS and Android, and comes in black, gold and mocha gold, making it a stylish choice for tech‑savvy health‑conscious users. Huawei priced the D3 at £399.99 in the UK, positioning it as a premium but affordable health accessory.
Industry analysts suggest the D3 could disrupt the wearable market by merging fitness tracking with clinically relevant health data. Huawei plans to roll out the watch in other European markets next quarter, and early adopters are already lining up to test the device’s accuracy against clinic‑grade monitors.